Intravacc collaborates with a diverse network of global partners, including universities, government institutions, biotech, and pharmaceutical companies, to strengthen our mission of advancing promising vaccine candidates through the development pipeline. We specialize in innovative vaccine concepts and provide tailored solutions to meet unique needs.
Our state-of-the-art facilities are equipped to work with various vaccine platforms, allowing us to produce customized GMP-grade pilot lots that support your phase I or II clinical trials. We are currently engaged in active partnerships with biotech and government organizations, via various collaboration models, including licensing agreements.
In conjunction with our partners, we actively participate in obtaining public funding for the development of novel vaccine concepts and clinical studies. Several projects are currently underway.
Intravacc offers non-exclusive partnership opportunities for several proprietary technologies, including:
Join us in advancing vaccine innovation and global health solutions through collaborative partnerships. Contact us to explore how we can work together.